Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of the American Academy of Dermatology|March 24, 2016
ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practiceEva Vilarrasa, Jaume Notario, Xavier Bordas, et al.Glycoconjugate Journal|September 1, 2005
Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cellsRosa Peracaula, Glòria Tabarés, Anna López-Ferrer, et al.International Journal of Clinical Pharmacy|April 5, 2022
A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherenceDavid Medina-Catalán, Pau Riera, Neus Pagès-Puigdemont, et al.Cancer|December 11, 2025
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemiaMiguel Arguello-Tomas, Elionor Lynton-Pons, Nil Albiol, et al.Journal of Clinical Medicine|November 27, 2025
An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin CancerPablo Balado-Simó, Daniel Morgado-Carrasco, Sara Gómez-Armayones, et al.The Journal of Dermatological Treatment|August 9, 2017
Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health ServiceLluís Puig, Jaume Notario, Alberto Jiménez-Morales, et al.Actas Dermo-Sifiliograficas|March 21, 2026
Management of the Impact of Psoriasis on Sexuality: Consensus Recommendations From the Psoriasis Working Group of the Spanish Academy of Dermatology and VenereologyRaquel Tulleuda, Salvador Arias-Santiago, Susana Armesto, et al.Rheumatology (Oxford, England)|November 8, 2025
Chronic inflammatory burden on aortic valve disorders and atrioventricular block risk in spondyloarthritis: an ambispective cohort studyHye Sang Park, Ana Laiz, Jesus Sánchez-Vega, et al.JAMA Dermatology|February 18, 2026
Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label ExtensionMatthias Augustin, Steven R Feldman, Richard B Warren, et al.The Journal of Dermatological Treatment|March 19, 2019
Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter studyElena Del Alcázar, Marta Ferran, Anna López-Ferrer, et al.Pageof 3